Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hussein Arkhagha Insider Profile
4 Followers
Hussein Arkhagha, Chief People Officer at Hikma Pharmaceuticals, holds ― shares in Hikma Pharmaceuticals (Ticker: GB:HIK).
Hussein Arkhagha has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Hussein Arkhagha does not currently own shares as a corporate insider.
A breakdown of Hussein Arkhagha's holdings
Insider Roles
Chief People Officer
Roles that Hussein Arkhagha holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 20, 2020 - May 20, 2021
Return:-0.10%
The most profitable trade made by Hussein Arkhagha
Hussein Arkhagha's Trading History
List of latest transactions for each holding click on a transaction to see Hussein Arkhagha's performance on stock
You May Also Like
Hussein Arkhagha insider profile FAQ
What is the percentage of profitable transactions made by Hussein Arkhagha?
The percentage of profitable transactions made by Hussein Arkhagha is ―.
What is the average return per transaction made by Hussein Arkhagha?
The average return per transaction made by Hussein Arkhagha is ―.
What stocks does Hussein Arkhagha hold?
Hussein Arkhagha holds: GB:HIK stocks.
What was Hussein Arkhagha’s latest transaction?
Hussein Arkhagha latest transaction was an Uninformative Buy of 8.78K.
What was Hussein Arkhagha's most profitable transaction?
Hussein Arkhagha’s most profitable transaction was an Informative Sell of GB:HIK stock on May 20, 2020. The return on the trade was -0.10%.
What is Hussein Arkhagha's role in Hikma Pharmaceuticals?
Hussein Arkhagha's role in Hikma Pharmaceuticals is Chief People Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.